BSE filing, NSE: FRSHTRP. Summary written from the filing by ALFA Finder's alert engine.
Puretrop Fruits Ltd: key numbers
- Share price
- ₹181.00
- Market cap
- ₹144.3 Cr
- Revenue (annual)
- ₹121.9 Cr
- Net profit (annual)
- ₹25.29 Cr
- P/E (TTM)
- 10.8×Sector 26.8×
- Promoter holding
- 64.27%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Puretrop Fruits Ltd
All →Puretrop Fruits Q2 FY27 Results: Net Profit ₹2.4 Cr, Down 33.3% YoY
Puretrop Fruits Ltd reported revenue from operations of ₹26.4 Cr (-1.9% YoY) and net profit of ₹2.4 Cr (-33.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.4 Cr · -33.3% YoY
Puretrop Fruits Board Meeting Date
Puretrop Fruits Ltd scheduled a board meeting for 27 October 2026 to approve unaudited Q1 and H1 standalone results. No financial figures are disclosed in this intimation.
Puretrop Fruits Other Announcement
Puretrop Fruits Ltd filed its quarterly shareholding pattern as mandated under SEBI Regulation 31(1)(b) for the period ending September 30, 2026.
Puretrop Fruits Annual General Meeting
Puretrop Fruits held its 34th AGM on September 15, 2026, through video conferencing. The meeting covered routine business, including the adoption of financial statements and director appointments.
Puretrop Fruits Annual Report
Puretrop Fruits Limited has submitted its 34th Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 15, 2026, via video conferencing.
Puretrop Fruits Annual General Meeting
Puretrop Fruits Limited issued the notice for its 34th Annual General Meeting scheduled for September 15, 2026. The meeting will be conducted via video conferencing.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.